Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 15 articles:
HTML format
Text format

Single Articles

    July 2019
  1. SAJIKI Y, Konnai S, Okagawa T, Nishimori A, et al
    Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection.
    J Immunol. 2019 Jul 31. pii: jimmunol.1900342. doi: 10.4049/jimmunol.1900342.
    PubMed     Text format     Abstract available

    April 2019
  2. GUPTA R, Li W, Yan XJ, Barrientos J, et al
    Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.
    J Immunol. 2019 Apr 15. pii: jimmunol.1801142. doi: 10.4049/jimmunol.1801142.
    PubMed     Text format     Abstract available

    February 2019
  3. ARRUDA LCM, Gaballa A, Uhlin M
    Graft gammadelta TCR Sequencing Identifies Public Clonotypes Associated with Hematopoietic Stem Cell Transplantation Efficacy in Acute Myeloid Leukemia Patients and Unravels Cytomegalovirus Impact on Repertoire Distribution.
    J Immunol. 2019 Feb 1. pii: jimmunol.1801448. doi: 10.4049/jimmunol.1801448.
    PubMed     Text format     Abstract available

  4. KAUR M, Drake AC, Hu G, Rudnick S, et al
    Induction and Therapeutic Targeting of Human NPM1c(+) Myeloid Leukemia in the Presence of Autologous Immune System in Mice.
    J Immunol. 2019 Feb 1. pii: jimmunol.1800366. doi: 10.4049/jimmunol.1800366.
    PubMed     Text format     Abstract available

    January 2019
  5. BALLESTEROS-ARIAS L, Silva JG, Paiva RA, Carbonetto B, et al
    T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy.
    J Immunol. 2019 Jan 16. pii: jimmunol.1801373. doi: 10.4049/jimmunol.1801373.
    PubMed     Text format     Abstract available

    November 2018
  6. KLINE DE, MacNabb BW, Chen X, Chan WC, et al
    CD8alpha(+) Dendritic Cells Dictate Leukemia-Specific CD8(+) T Cell Fates.
    J Immunol. 2018 Nov 12. pii: jimmunol.1801184. doi: 10.4049/jimmunol.1801184.
    PubMed     Text format     Abstract available

    August 2018
  7. AUE G, Sun C, Liu D, Park JH, et al
    Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
    J Immunol. 2018 Aug 13. pii: jimmunol.1800570. doi: 10.4049/jimmunol.1800570.
    PubMed     Text format     Abstract available

  8. GUPTA R, Yan XJ, Barrientos J, Kolitz JE, et al
    Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.
    J Immunol. 2018 Aug 1. pii: jimmunol.1800591. doi: 10.4049/jimmunol.1800591.
    PubMed     Text format     Abstract available

    July 2018
  9. YANG TH, St John LS, Garber HR, Kerros C, et al
    Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation.
    J Immunol. 2018 Jul 18. pii: jimmunol.1800324. doi: 10.4049/jimmunol.1800324.
    PubMed     Text format     Abstract available

    June 2018
  10. STERNER RM, Kremer KN, Dudakovic A, Westendorf JJ, et al
    Tissue-Nonspecific Alkaline Phosphatase Is Required for MC3T3 Osteoblast-Mediated Protection of Acute Myeloid Leukemia Cells from Apoptosis.
    J Immunol. 2018 Jun 18. pii: jimmunol.1800174. doi: 10.4049/jimmunol.1800174.
    PubMed     Text format     Abstract available

    April 2018
  11. ALHAKEEM SS, McKenna MK, Oben KZ, Noothi SK, et al
    Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
    J Immunol. 2018 Apr 30. pii: jimmunol.1800241. doi: 10.4049/jimmunol.1800241.
    PubMed     Text format     Abstract available

  12. PALAZZO A, Herter S, Grosmaire L, Jones R, et al
    The PI3Kdelta-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo.
    J Immunol. 2018;200:2304-2312.
    PubMed     Text format     Abstract available

    October 2017
  13. KIM YH, Kumar A, Chang CH, Pyaram K, et al
    Reactive Oxygen Species Regulate the Inflammatory Function of NKT Cells through Promyelocytic Leukemia Zinc Finger.
    J Immunol. 2017 Oct 11. pii: ji1700567. doi: 10.4049/jimmunol.1700567.
    PubMed     Text format     Abstract available

    September 2017
  14. SUN HM, Chen XL, Chen XJ, Liu J, et al
    PALLD Regulates Phagocytosis by Enabling Timely Actin Polymerization and Depolymerization.
    J Immunol. 2017;199:1817-1826.
    PubMed     Text format     Abstract available

    July 2017
  15. SKOPELJA-GARDNER S, Jones JD, Hamilton BJ, Danilov AV, et al
    Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.
    J Immunol. 2017 Jul 14. pii: ji1602105. doi: 10.4049/jimmunol.1602105.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.